NDC 0054-0188 – Buprenorphine and naloxone

Buprenorphine Hydrochloride 2 mg/1; Naloxone Hydrochloride Dihydrate .5 mg/1 · Tablet · Sublingual

Human Prescription Drug DEA schedule CIII

Product NDC0054-0188

Product details

Brand name
Buprenorphine and naloxone
Generic name
Buprenorphine and naloxone
Labeler
Hikma Pharmaceuticals USA Inc.
Dosage form
Tablet
Route
Sublingual
Marketing category
ANDA · ANDA203326
Marketed since
June 27, 2014
Listing expires
December 31, 2027
Pharmacologic class
Opioid Antagonist; Partial Opioid Agonist

Active ingredients

Uses, dosage, side effects and warnings for Buprenorphine and Naloxone →

Package NDC codes (1)

Package NDCDescriptionSince
0054-0188-1330 TABLET in 1 BOTTLE (0054-0188-13)Jun 27, 2014

Other Buprenorphine and Naloxone products